BASIL: Antimicrobial resistance among agents of community-associated lower respiratory tract infection: UK and Ireland trends from 1999/2000 to 2018/2019

Reynolds, Rosy, Felmingham, David, Mushtaq, Shazad, Horner, Carolyne, Chaudhry, Aiysha, Adkin, Rachael, Allen, Michael, Longshaw, Christopher, Parcell, Benjamin J. and Livermore, David M. (2025) BASIL: Antimicrobial resistance among agents of community-associated lower respiratory tract infection: UK and Ireland trends from 1999/2000 to 2018/2019. Journal of Antimicrobial Chemotherapy. ISSN 0305-7453 (In Press)

PDF (06_CA-LRTI-R1 final) - Accepted Version Restricted to Repository staff only until 31 December 2099. Request a copy

Abstract

Objectives. The BSAC Respiratory Surveillance Programme examined resistance trends among Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired lower respiratory tract infection (CA-LRTI). Methods. Quotas of isolates were sought per collecting site from 1999/00 to 2018/19; an annual October start date captured winter infection peaks within single years. MIC testing was by BSAC agar dilution, β-lactamase detection with nitrocefin, pneumococcal serotyping by classical methods or WGS. Results. Resistances were uncommon, except that β-lactamases occurred in c. 20% H. influenzae from 2012/13 following earlier rises, and in >90% of M. catarrhalis throughout. Only 12/10881 S. pneumoniae were fully resistant to penicillin; co-amoxiclav inhibited 97.8% of 13526 H. influenzae and >99.9% of 6309 M. catarrhalis isolates. Cefotaxime inhibited >99% of all isolates at breakpoint, as did other fluoroquinolones in the fewer years tested. Tetracycline inhibited >98% of H. influenzae and M. catarrhalis, also 85% of S. pneumoniae. Significant shifts were (i) fluctuating resistances to tetracyclines, macrolides and penicillin in pneumococci, reflecting serotype replacements; (ii) expansion, from 2012/13, in the proportion of H. influenzae with β-lactamase-independent amoxicillin/co-amoxiclav resistance and (iii) increasing high-level amoxicillin resistance (MIC >64 mg/L) in β-lactamase-positive H. influenzae. MIC differentials were seen for cephalosporins between β-lactamase-positive and -negative M. catarrhalis, greatest (512-fold) for ceftaroline. Conclusion. CA-LRTI remains eminently treatable, yet shifts are occurring in the serotypes of S. pneumoniae most associated with resistance and in the nature of amoxicillin resistance in H. influenzae. β-Lactamase-related cephalosporin MIC differentials for M. catarrhalis are striking; their clinical significance remains uncertain.

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Epidemiology and Public Health
Depositing User:	LivePure Connector
Date Deposited:	14 Oct 2025 10:34
Last Modified:	14 Oct 2025 14:33
URI:	https://ueaeprints.uea.ac.uk/id/eprint/100714
DOI:

Actions (login required)

View Item